BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $63.37 -1.08%
EPS Growth %: +1,008.3%
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +1,008.3%
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.53), which may not compare to the analyst estimate of ($0.38). Revenue for the quarter came in at $300 million versus the consensus estimate of $295.96 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Orosur Mining launches private placement targeting C$14M
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
